Lauren A Paul1, Nick Daneman1,2,3,4,5, Kevin L Schwartz1,6,7, Michelle Science1,8,9, Kevin A Brown1,6, Michael Whelan1, Ellen Chan1, Sarah A Buchan1,6. 1. Health Protection, Public Health Ontario, Toronto, Ontario, Canada. 2. Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 3. Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 4. Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 5. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. 6. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 7. Unity Health Toronto-St Joseph's Health Centre, Toronto, Ontario, Canada. 8. Division of Infectious Diseases, The Hospital for Sick Children, Toronto, Ontario, Canada. 9. Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.
Abstract
Importance: As a result of low numbers of pediatric cases early in the COVID-19 pandemic, pediatric household transmission of SARS-CoV-2 remains an understudied topic. Objective: To determine whether there are differences in the odds of household transmission by younger children compared with older children. Design, Setting, and Participants: This population-based cohort study took place between June 1 and December 31, 2020, in Ontario, Canada. Private households in which the index case individual of laboratory-confirmed SARS-CoV-2 infection was younger than 18 years were included. Individuals were excluded if they resided in apartments missing suite information, in households with multiple index cases, or in households where the age of the index case individual was missing. Exposures: Age group of pediatric index cases categorized as 0 to 3, 4 to 8, 9 to 13, and 14 to 17 years. Main Outcomes and Measures: Household transmission, defined as households where at least 1 secondary case occurred 1 to 14 days after the pediatric index case. Results: A total of 6280 households had pediatric index cases, and 1717 households (27.3%) experienced secondary transmission. The mean (SD) age of pediatric index case individuals was 10.7 (5.1) years and 2863 (45.6%) were female individuals. Children aged 0 to 3 years had the highest odds of transmitting SARS-CoV-2 to household contacts compared with children aged 14 to 17 years (odds ratio, 1.43; 95% CI, 1.17-1.75). This association was similarly observed in sensitivity analyses defining secondary cases as 2 to 14 days or 4 to 14 days after the index case and stratified analyses by presence of symptoms, association with a school/childcare outbreak, or school/childcare reopening. Children aged 4 to 8 years and 9 to 13 years also had increased odds of transmission (aged 4-8 years: odds ratio, 1.40; 95% CI, 1.18-1.67; aged 9-13 years: odds ratio, 1.13; 95% CI, 0.97-1.32). Conclusions and Relevance: This study suggests that younger children may be more likely to transmit SARS-CoV-2 infection compared with older children, and the highest odds of transmission was observed for children aged 0 to 3 years. Differential infectivity of pediatric age groups has implications for infection prevention within households, as well as schools/childcare, to minimize risk of household secondary transmission. Additional population-based studies are required to establish the risk of transmission by younger pediatric index cases.
Importance: As a result of low numbers of pediatric cases early in the COVID-19 pandemic, pediatric household transmission of SARS-CoV-2 remains an understudied topic. Objective: To determine whether there are differences in the odds of household transmission by younger children compared with older children. Design, Setting, and Participants: This population-based cohort study took place between June 1 and December 31, 2020, in Ontario, Canada. Private households in which the index case individual of laboratory-confirmed SARS-CoV-2 infection was younger than 18 years were included. Individuals were excluded if they resided in apartments missing suite information, in households with multiple index cases, or in households where the age of the index case individual was missing. Exposures: Age group of pediatric index cases categorized as 0 to 3, 4 to 8, 9 to 13, and 14 to 17 years. Main Outcomes and Measures: Household transmission, defined as households where at least 1 secondary case occurred 1 to 14 days after the pediatric index case. Results: A total of 6280 households had pediatric index cases, and 1717 households (27.3%) experienced secondary transmission. The mean (SD) age of pediatric index case individuals was 10.7 (5.1) years and 2863 (45.6%) were female individuals. Children aged 0 to 3 years had the highest odds of transmitting SARS-CoV-2 to household contacts compared with children aged 14 to 17 years (odds ratio, 1.43; 95% CI, 1.17-1.75). This association was similarly observed in sensitivity analyses defining secondary cases as 2 to 14 days or 4 to 14 days after the index case and stratified analyses by presence of symptoms, association with a school/childcare outbreak, or school/childcare reopening. Children aged 4 to 8 years and 9 to 13 years also had increased odds of transmission (aged 4-8 years: odds ratio, 1.40; 95% CI, 1.18-1.67; aged 9-13 years: odds ratio, 1.13; 95% CI, 0.97-1.32). Conclusions and Relevance: This study suggests that younger children may be more likely to transmit SARS-CoV-2 infection compared with older children, and the highest odds of transmission was observed for children aged 0 to 3 years. Differential infectivity of pediatric age groups has implications for infection prevention within households, as well as schools/childcare, to minimize risk of household secondary transmission. Additional population-based studies are required to establish the risk of transmission by younger pediatric index cases.
Authors: Ran D Goldman; Jeffrey N Bone; Renana Gelernter; Danna Krupik; Samina Ali; Ahmed Mater; Graham C Thompson; Kenneth Yen; Mark A Griffiths; Adi Klein; Eileen J Klein; Rakesh D Mistry; Jeanine E Hall; Julie C Brown Journal: Hum Vaccin Immunother Date: 2021-11-19 Impact factor: 3.452
Authors: Costanza Di Chiara; Anna Cantarutti; Paola Costenaro; Daniele Donà; Francesco Bonfante; Chiara Cosma; Martina Ferrarese; Sandra Cozzani; Maria Raffaella Petrara; Francesco Carmona; Cecilia Liberati; Paolo Palma; Giovanni Di Salvo; Anita De Rossi; Mario Plebani; Andrea Padoan; Carlo Giaquinto Journal: JAMA Netw Open Date: 2022-07-01
Authors: Marcelo U Ferreira; Isabel Giacomini; Priscila M Sato; Barbara H Lourenço; Vanessa C Nicolete; Lewis F Buss; Alicia Matijasevich; Marcia C Castro; Marly A Cardoso Journal: PLoS Negl Trop Dis Date: 2022-07-18
Authors: Huong Q McLean; Carlos G Grijalva; Kayla E Hanson; Yuwei Zhu; Jessica E Deyoe; Jennifer K Meece; Natasha B Halasa; James D Chappell; Alexandra M Mellis; Carrie Reed; Edward A Belongia; H Keipp Talbot; Melissa A Rolfes Journal: Pediatrics Date: 2022-03-01 Impact factor: 9.703
Authors: Maala Bhatt; Amy C Plint; Ken Tang; Richard Malley; Anne Pham Huy; Candice McGahern; Jennifer Dawson; Martin Pelchat; Lauren Dawson; Terry Varshney; Corey Arnold; Yannick Galipeau; Michael Austin; Nisha Thampi; Fuad Alnaji; Marc-André Langlois; Roger L Zemek Journal: CMAJ Open Date: 2022-04-12
Authors: Huong Q McLean; Carlos G Grijalva; Kayla E Hanson; Yuwei G Zhu; Jessica E Deyoe; Jennifer K Meece; Natasha B Halasa; James D Chappell; Alexandra Mellis; Carrie Reed; Edward A Belongia; H Keipp Talbot; Melissa A Rolfes Journal: medRxiv Date: 2021-08-20
Authors: Melissa Lucero Tanaka; Carolyn Jennifer Marentes Ruiz; Sanchi Malhotra; Lauren Turner; Ariana Peralta; Yesun Lee; Jaycee Jumarang; Stephanie E Perez; Jocelyn Navarro; Jennifer Dien Bard; Aubree Gordon; E Kaitlynn Allen; Paul G Thomas; Pia S Pannaraj Journal: Front Pediatr Date: 2022-01-05 Impact factor: 3.569